LMNX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide...

Stats
Dagens volum	1.02M
Gjennomsnittsvolum	650 237
Markedsverdi	0.00
EPS	$0.190 ( Q1 \| 2021-05-05 )
Last Dividend	$0.100 ( 2021-06-16 )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 0
ATR14	$0.188 (0.51%)

AKYA -6.41%

ANGO -5.21%

APR 0.00%

ATRC -1.69%

ATRI -0.03%

ATRS 0.18%

AVGR -8.33%

AZTA -3.13%

BLFS -4.04%

EKSO -0.95%

FEMY 2.63%

GMVD 1.38%

HBIO -1.40%

HOLX -0.46%

ICUI -3.20%

IIN 0.12%

ISRG -2.27%

KRMD -11.70%

LMAT -2.99%

LMNX 0.00%

MASI -6.72%

MBOT -0.99%

MHUA 16.86%

MMSI -0.57%

NEPH -0.71%

NSTG -37.43%

NVCR 2.57%

NXGL -1.00%

OSUR -0.94%

PDEX -6.82%

PLSE -2.86%

POAI -0.96%

QDEL -3.73%

RGEN -2.27%

SDC -53.45%

SMTI -4.33%

STAA -0.46%

STSS -3.18%

UTMD 0.15%

XRAY -1.16%

ZTEK 0.00%

Insider Trading

Date	Person	Action	Amount	type
2021-07-14	Ogunro Edward A	Sell	10 760	Common Stock
2021-07-14	Ogunro Edward A	Sell	50 133	Common Stock
2021-07-14	Mcnamara Kevin M	Sell	24 443	Common Stock
2021-07-14	Mcnamara Kevin M	Sell	75 925	Common Stock
2021-07-14	Erickson Thomas W	Sell	79 204	Common Stock

INSIDER POWER
0.00
Last 100 transactions
Buy: 1 457 367 \| Sell: 3 933 642

Volum Korrelasjon

Lang: 0.06 (neutral)

Kort: 0.88 (strong)

Signal:(63.839) Same movement expected

Luminex Corporation Korrelasjon

10 Mest positive korrelasjoner
DSPG	0.935
STAY	0.893
MSON	0.868
PPD	0.857
DVCR	0.838
CHMA	0.834
MDCA	0.827
MXIM	0.813
GAINM	0.811

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Luminex Corporation Korrelasjon - Valuta/Råvare

-0.35
( neutral )

-0.23
( neutral )

-0.65
( moderate negative )

0.16
( neutral )

0.89
( strong )

0.50
( neutral )

Luminex Corporation Økonomi

Annual	2020
Omsetning:	$417.40M
Bruttogevinst:	$247.85M (59.38 %)
EPS:	$0.336

FY	2020
Omsetning:	$417.40M
Bruttogevinst:	$247.85M (59.38 %)
EPS:	$0.336

FY	2019
Omsetning:	$334.64M
Bruttogevinst:	$182.74M (54.61 %)
EPS:	$-0.0900

FY	2018
Omsetning:	$315.82M
Bruttogevinst:	$195.49M (61.90 %)
EPS:	$0.420

Financial Reports:

No articles found.

Luminex Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Luminex Corporation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.83 - No dividend growth expected in the near future

Information

First Dividend	$0.0600	2017-03-22
Last Dividend	$0.100	2021-06-16
Next Dividend	$0	N/A
Payout Date	2021-07-08
Next Payout Date	N/A
# dividends	18	--
Total Paid Out	$1.350	--
Avg. Dividend % Per Year	0.22%	--
Score	4.31	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.83
Div. Directional Score	8.48	--

Next Divdend (Est)
(2024-09-26)

$0 Estimate 0.00 %

Dividend Stability

0.14 Bad

Dividend Score

4.31

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2017	$0.240	1.18%
2018	$0.240	1.18%
2019	$0.300	1.32%
2020	$0.370	1.61%
2021	$0.200	0.82%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
16 Jun 2021	$0.100	20 May 2021	17 Jun 2021	08 Jul 2021
24 Mar 2021	$0.100	09 Feb 2021	25 Mar 2021	15 Apr 2021
22 Dec 2020	$0.100	08 Dec 2020	23 Dec 2020	14 Jan 2021
23 Sep 2020	$0.0900	16 Sep 2020	24 Sep 2020	15 Oct 2020
17 Jun 2020	$0.0900	26 May 2020	18 Jun 2020	09 Jul 2020
18 Mar 2020	$0.0900	18 Feb 2020	19 Mar 2020	09 Apr 2020
18 Dec 2019	$0.0900	09 Dec 2019	19 Dec 2019	15 Jan 2020
25 Sep 2019	$0.0900	31 Jul 2019	26 Sep 2019	17 Oct 2019
19 Jun 2019	$0.0600	21 May 2019	20 Jun 2019	11 Jul 2019
20 Mar 2019	$0.0600	11 Feb 2019	21 Mar 2019	11 Apr 2019
19 Dec 2018	$0.0600	12 Dec 2018	20 Dec 2018	10 Jan 2019
20 Sep 2018	$0.0600	12 Sep 2018	21 Sep 2018	12 Oct 2018
21 Jun 2018	$0.0600	18 May 2018	22 Jun 2018	13 Jul 2018
22 Mar 2018	$0.0600	24 Jan 2018	23 Mar 2018	13 Apr 2018
21 Dec 2017	$0.0600	14 Dec 2017	22 Dec 2017	12 Jan 2018
21 Sep 2017	$0.0600	12 Sep 2017	22 Sep 2017	13 Oct 2017
21 Jun 2017	$0.0600	25 May 2017	23 Jun 2017	14 Jul 2017
22 Mar 2017	$0.0600	22 Feb 2017	24 Mar 2017	14 Apr 2017

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0363	1.500	9.27	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0197	1.200	9.34	10.00	[0 - 0.3]
returnOnEquityTTM	0.0309	1.500	-0.768	-1.152	[0.1 - 1]
payoutRatioTTM	1.087	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	5.82	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.30	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	3.54	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.271	-1.500	5.48	-8.21	[0 - 0.6]
interestCoverageTTM	3.56	1.000	9.79	9.79	[3 - 30]
operatingCashFlowPerShareTTM	1.090	2.00	9.64	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.699	2.00	9.65	10.00	[0 - 20]
debtEquityRatioTTM	0.404	-1.500	8.38	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.594	1.000	3.44	3.44	[0.2 - 0.8]
operatingProfitMarginTTM	0.102	1.000	9.97	9.97	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.239	1.000	9.78	9.78	[0.2 - 2]
assetTurnoverTTM	0.542	0.800	9.72	7.78	[0.5 - 2]
Total Score				13.13

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	111.73	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.0309	2.50	-0.494	-1.152	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.699	2.00	9.77	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.090	2.00	9.64	10.00	[0 - 30]
payoutRatioTTM	1.087	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-17.50	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.120	1.000	9.51	0	[0.1 - 0.5]
Total Score				3.83

Luminex Corporation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Luminex Corporation

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.